These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9830009)

  • 1. A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties.
    Reginato MJ; Bailey ST; Krakow SL; Minami C; Ishii S; Tanaka H; Lazar MA
    J Biol Chem; 1998 Dec; 273(49):32679-84. PubMed ID: 9830009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAT5A: a partial agonist of peroxisome proliferator-activated receptor gamma is a potent antidiabetic thiazolidinedione yet weakly adipogenic.
    Misra P; Chakrabarti R; Vikramadithyan RK; Bolusu G; Juluri S; Hiriyan J; Gershome C; Rajjak A; Kashireddy P; Yu S; Surapureddi S; Qi C; Zhu YJ; Rao MS; Reddy JK; Ramanujam R
    J Pharmacol Exp Ther; 2003 Aug; 306(2):763-71. PubMed ID: 12730351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
    Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
    Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2.
    Li Y; Lazar MA
    Mol Endocrinol; 2002 May; 16(5):1040-8. PubMed ID: 11981038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
    Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB
    Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
    Rieusset J; Touri F; Michalik L; Escher P; Desvergne B; Niesor E; Wahli W
    Mol Endocrinol; 2002 Nov; 16(11):2628-44. PubMed ID: 12403851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
    Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
    Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.
    Berger JP; Petro AE; Macnaul KL; Kelly LJ; Zhang BB; Richards K; Elbrecht A; Johnson BA; Zhou G; Doebber TW; Biswas C; Parikh M; Sharma N; Tanen MR; Thompson GM; Ventre J; Adams AD; Mosley R; Surwit RS; Moller DE
    Mol Endocrinol; 2003 Apr; 17(4):662-76. PubMed ID: 12554792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
    Kallen CB; Lazar MA
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5793-6. PubMed ID: 8650171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
    Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J
    Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis.
    Wang M; Tafuri S
    J Cell Biochem; 2003 May; 89(1):38-47. PubMed ID: 12682906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes.
    Camp HS; Chaudhry A; Leff T
    Endocrinology; 2001 Jul; 142(7):3207-13. PubMed ID: 11416043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro.
    Su JL; Winegar DA; Wisely GB; Sigel CS; Hull-Ryde EA
    Hybridoma; 1999 Jun; 18(3):273-80. PubMed ID: 10475242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.
    Adams M; Montague CT; Prins JB; Holder JC; Smith SA; Sanders L; Digby JE; Sewter CP; Lazar MA; Chatterjee VK; O'Rahilly S
    J Clin Invest; 1997 Dec; 100(12):3149-53. PubMed ID: 9399962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608.
    Wiesenberg I; Chiesi M; Missbach M; Spanka C; Pignat W; Carlberg C
    Mol Pharmacol; 1998 Jun; 53(6):1131-8. PubMed ID: 9614218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor Fos-related antigen 1 is induced by thiazolidinediones during differentiation of 3T3-L1 cells.
    Albrektsen T; Fleckner J
    Mol Pharmacol; 2001 Mar; 59(3):567-75. PubMed ID: 11179452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect.
    Armoni M; Kritz N; Harel C; Bar-Yoseph F; Chen H; Quon MJ; Karnieli E
    J Biol Chem; 2003 Aug; 278(33):30614-23. PubMed ID: 12777391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidinedione- and tumor necrosis factor alpha-induced downregulation of peroxisome proliferator-activated receptor gamma mRNA in differentiated 3T3-L1 adipocytes.
    Perrey S; Ishibashi S; Yahagi N; Osuga J; Tozawa R; Yagyu H; Ohashi K; Gotoda T; Harada K; Chen Z; Iizuka Y; Shionoiri F; Yamada N
    Metabolism; 2001 Jan; 50(1):36-40. PubMed ID: 11172472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.
    Berger J; Tanen M; Elbrecht A; Hermanowski-Vosatka A; Moller DE; Wright SD; Thieringer R
    J Biol Chem; 2001 Apr; 276(16):12629-35. PubMed ID: 11278270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.